市場調查報告書
商品編碼
1017286

人工角膜及角膜植入市場成長機會·成長預測 (2021-2028年):角膜類型·移植類型·適應症·終端用戶·各地區

Artificial Cornea and Corneal Implant Market by Type, Transplant Type, Disease Indication, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2028

出版日期: | 出版商: Allied Market Research | 英文 215 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球人工角膜及角膜植入的市場規模在預測期間內預計將以7.9%的年複合成長率推移,從2020年的3億7661萬美元,成長到2028年6億5619萬美元的規模。

老年人口的增加,眼科疾病的劇增,政府的配合措施等要素正在推動市場的增長。另一方面,眼科醫療設備和手術的高成本預計將在預測期內抑制市場增長。

本報告提供全球人工角膜及角膜植入的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的轉變·預測,角膜類型·移植類型·適應症·終端用戶·地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義·範圍
  • 主要調查結果
  • 波特的五力分析
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • COVID-19:影響分析

第4章 市場分析·預測:各角膜類型

  • 人角膜
  • 人工角膜
    • 主要趨勢·成長機會
    • 市場規模·預測
    • 市場分析:各國

第5章 市場分析·預測:各移植類型

  • 角膜移植
  • 內皮層角膜移植
  • 前部層狀角膜移植
  • 角膜假體
    • 市場規模·預測
    • 市場分析:各國

第6章 市場分析·預測:各適應症

  • 角膜失養症
  • 真菌性角膜炎
  • 圓錐角膜
  • 其他
    • 市場規模·預測
    • 市場分析:各國

第7章 市場分析·預測:各終端用戶

  • 醫院·門診病人手術中心
  • 專門診所
    • 市場規模·預測
    • 市場分析:各國

第8章 市場分析·預測:地區·各主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲
    • 主要趨勢·成長機會
    • 市場規模·預測:各國
    • 市場規模·預測:各角膜類型
    • 市場規模·預測:各移植類型
    • 市場規模·預測:各適應症
    • 市場規模·預測:各終端用戶

第9章 企業簡介

  • AJL Ophthalmic
  • CorneaGen Inc
  • CorNeat Vision
  • LinkoCare Life Sciences AB
  • Presbia plc
  • Mediphacos
  • Aurolab
  • Cornea Biosciences
  • DIOPTEX GmbH
  • EyeYon Medical
目錄
Product Code: A11333

The global artificial cornea and corneal implant market generated $376.61 million in 2020 and is projected to reach $656.19 million by 2028, growing at a CAGR of 7.9% from 2021 to 2028.

A corneal transplant involves replacing a cloudy cornea with a clear donor cornea. Donor tissue comes from individuals who have donated their eyes for the benefit of others. The donor corneas used in transplants are kept freshly stored in eye banks. Furthermore, artificial cornea is an option for transplant patients who cannot tolerate a human donor cornea.

The global artificial cornea and corneal implant market is expected to witness a substantial growth in the future, driven by the rise in geriatric population and surge in prevalence of eye diseases. In addition, increase in prevalence of eye disorders and government initiatives to control visual impairment further boost the market growth. However, the high cost of ophthalmology devices and surgical procedures is expected to restrain the growth of the market during the forecast period.

Around 10 million people in world are reported to suffer from corneal blindness. Therefore, rise in incidences of corneal blindness is the primary factor that drives the growth of the artificial cornea implant market. Moreover, lack of availability of human cornea donor is responsible for the robust growth of the market. In addition, increase in incidences of trauma cases lead to high chances of eye injury, which further propel the market growth. The possibility of nerve regeneration after cornea transplant by human donor cornea is low while the possibility of nerve regeneration after biosynthetic cornea implant is high. The rejection of artificial cornea made up of alloplastic material by human eye is expected to be the major factor that restrains the growth of the market. Artificial cornea implant is a costly surgery, therefore the adoption for this surgery is quite low in the developing countries which deters the growth of the market during the forecast period. In addition, low availability of human cornea donor and high risk in the grafting artificial cornea implant have made a huge impact in the global market.

The artificial cornea and corneal implant market is segmented on the basis of type, transplant type, disease indication, end user, and region. By type, the market is divided into human cornea and artificial cornea. By transplant type, it is categorized into penetrating keratoplasty, endothelial keratoplasty, anterior lamellar keratoplasty and keratoprosthesis. By disease indication, the market is divided into Fuchs' Dystrophy, Fungal Keratitis, Keratoconus and others. By end user, the market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA)..

The key players operating in the global artificial cornea and corneal implant market include AJL Ophthalmic, CorneaGen Inc., CorNeat Vision, LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab, Cornea Biosciences, DIOPTEX GmbH, EyeYon Medical.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the artificial cornea and corneal implant market, and the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis of the market from 2020 to 2028 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the trends in artificial cornea and corneal implant globally
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Type

  • Human Cornea
  • Artificial Cornea

By Transplant Type

  • Penetrating Keratoplasty
  • Endothelial Keratoplasty
  • Anterior lamellar keratoplasty
  • keratoprosthesis

By Disease Indication

  • Fuchs' Dystrophy
  • Fungal Keratitis
  • Keratoconus
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • AJL Ophthalmic
  • CorneaGen Inc.
  • CorNeat Vision
  • LinkoCare Life Sciences AB
  • Presbia plc
  • Mediphacos
  • Aurolab
  • Cornea Biosciences
  • DIOPTEX GmbH
  • EyeYon Medical

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key Findings of the Study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Rise in prevalence of eye diseases across the globe
      • 3.4.1.2.Surge in government initiatives to control visual impairment
      • 3.4.1.3.Growth in geriatric population
    • 3.4.2.Restraints
      • 3.4.2.1.High cost of ophthalmology devices and surgical procedures
      • 3.4.2.2.Low accessibility to eye care in low income countries
    • 3.4.3.Opportunity
      • 3.4.3.1.Shortage of corneal donors
  • 3.5.COVID-19 impact on the artificial cornea and corneal implant market

CHAPTER 4:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Human Cornea
    • 4.2.1.Key market trends and growth opportunities
    • 4.2.2.Market size and forecast
    • 4.2.3.Market analysis, by country
  • 4.3.Artificial Cornea
    • 4.3.1.Key market trends and growth opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market analysis, by country

CHAPTER 5:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Penetrating Keratoplasty
    • 5.2.1.Market size and forecast
    • 5.2.2.Market analysis, by country
  • 5.3.Endothelial Keratoplasty
    • 5.3.1.Market size and forecast
    • 5.3.2.Market analysis, by country
  • 5.4.Anterior lamellar keratoplasty
    • 5.4.1.Market size and forecast
    • 5.4.2.Market analysis, by country
  • 5.5.keratoprosthesis
    • 5.5.1.Market size and forecast
    • 5.5.2.Market analysis, by country

CHAPTER 6:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Fuchs' Dystrophy
    • 6.2.1.Market size and forecast
    • 6.2.2.Market analysis, by country
  • 6.3.FUNGAL KERATITIS
    • 6.3.1.Market size and forecast
    • 6.3.2.Market analysis, by country
  • 6.4.Keratoconus
    • 6.4.1.Market size and forecast
    • 6.4.2.Market analysis, by country
  • 6.5.Other Diseases
    • 6.5.1.Market size and forecast
    • 6.5.2.Market analysis, by country

CHAPTER 7:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.Hospitals & Ambulatory Surgical Centers
    • 7.2.1.Market size and forecast
    • 7.2.2.Market analysis, by country
  • 7.3.Specialty Clinics
    • 7.3.1.Market size and forecast
    • 7.3.2.Market analysis, by country

CHAPTER 8:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY REGION

  • 8.1.Overview
    • 8.1.1.Market size and forecast
  • 8.2.North America
    • 8.2.1.Key market trends and opportunities
    • 8.2.2.Market size and forecast, by country
    • 8.2.3.North America artificial cornea and corneal implant market by Type
    • 8.2.4.North America artificial cornea and corneal implant market by Transplant Type
    • 8.2.5.North America artificial cornea and corneal implant market by Disease Indication
    • 8.2.6.North America artificial cornea and corneal implant market by end user
      • 8.2.6.1.U.S.
      • 8.2.6.1.1.U.S. artificial cornea and corneal implant market by Type
      • 8.2.6.1.2.U.S. artificial cornea and corneal implant market by Transplant Type
      • 8.2.6.1.3.U.S. artificial cornea and corneal implant market by Disease Indication
      • 8.2.6.1.4.U.S. artificial cornea and corneal implant market by end user
      • 8.2.6.2.Canada
      • 8.2.6.2.1.Canada artificial cornea and corneal implant market by Type
      • 8.2.6.2.2.Canada artificial cornea and corneal implant market by Transplant Type
      • 8.2.6.2.3.Canada artificial cornea and corneal implant market by Disease Indication
      • 8.2.6.2.4.Canada artificial cornea and corneal implant market by end user
      • 8.2.6.3.Mexico
      • 8.2.6.3.1.Mexico artificial cornea and corneal implant market by Type
      • 8.2.6.3.2.Mexico artificial cornea and corneal implant market by Transplant Type
      • 8.2.6.3.3.Mexico artificial cornea and corneal implant market by Disease Indication
      • 8.2.6.3.4.Mexico artificial cornea and corneal implant market by end user
  • 8.3.Europe
    • 8.3.1.Key market trends and opportunities
    • 8.3.2.Market size and forecast, by country
    • 8.3.3.Europe artificial cornea and corneal implant market by Type
    • 8.3.4.Europe artificial cornea and corneal implant market by Transplant Type
    • 8.3.5.Europe artificial cornea and corneal implant market by Disease Indication
    • 8.3.6.Europe artificial cornea and corneal implant market by end user
      • 8.3.6.1.Germany
      • 8.3.6.1.1.Germany artificial cornea and corneal implant market by Type
      • 8.3.6.1.2.Germany artificial cornea and corneal implant market by Transplant Type
      • 8.3.6.1.3.Germany artificial cornea and corneal implant market by Disease Indication
      • 8.3.6.1.4.Germany artificial cornea and corneal implant market by end user
      • 8.3.6.2.France
      • 8.3.6.2.1.France artificial cornea and corneal implant market by Type
      • 8.3.6.2.2.France artificial cornea and corneal implant market by Transplant Type
      • 8.3.6.2.3.France artificial cornea and corneal implant market by Disease Indication
      • 8.3.6.2.4.France artificial cornea and corneal implant market by end user
      • 8.3.6.3.UK
      • 8.3.6.3.1.UK artificial cornea and corneal implant market by Type
      • 8.3.6.3.2.UK artificial cornea and corneal implant market by Transplant Type
      • 8.3.6.3.3.UK artificial cornea and corneal implant market by Disease Indication
      • 8.3.6.3.4.UK artificial cornea and corneal implant market by end user
      • 8.3.6.4.Rest of Europe
      • 8.3.6.4.1.Rest of Europe artificial cornea and corneal implant market by Type
      • 8.3.6.4.2.Rest of Europe artificial cornea and corneal implant market by Transplant Type
      • 8.3.6.4.3.Rest of Europe artificial cornea and corneal implant market by Disease Indication
      • 8.3.6.4.4.Rest of Europe artificial cornea and corneal implant market by end user
  • 8.4.Asia-Pacific
    • 8.4.1.Key market trends and opportunities
    • 8.4.2.Market size and forecast, by country
    • 8.4.3.Asia-Pacific artificial cornea and corneal implant market by Type
    • 8.4.4.Asia-Pacific artificial cornea and corneal implant market, by Transplant Type
    • 8.4.5.Asia-Pacific artificial cornea and corneal implant market, by Disease Indication
    • 8.4.6.Asia-Pacific artificial cornea and corneal implant market by end user
      • 8.4.6.1.Japan
      • 8.4.6.1.1.Japan artificial cornea and corneal implant market by Type
      • 8.4.6.1.2.Japan artificial cornea and corneal implant market by Transplant Type
      • 8.4.6.1.3.Japan artificial cornea and corneal implant market by Disease Indication
      • 8.4.6.1.4.Japan artificial cornea and corneal implant market by end user
      • 8.4.6.2.China
      • 8.4.6.2.1.China artificial cornea and corneal implant market by Type
      • 8.4.6.2.2.China artificial cornea and corneal implant market by Transplant Type
      • 8.4.6.2.3.China artificial cornea and corneal implant market by Disease Indication
      • 8.4.6.2.4.China artificial cornea and corneal implant market by end user
      • 8.4.6.3.Australia
      • 8.4.6.3.1.Australia artificial cornea and corneal implant market by Type
      • 8.4.6.3.2.Australia artificial cornea and corneal implant market by Transplant Type
      • 8.4.6.3.3.Australia artificial cornea and corneal implant market by Disease Indication
      • 8.4.6.3.4.Australia artificial cornea and corneal implant market by end user
      • 8.4.6.4.India
      • 8.4.6.4.1.India artificial cornea and corneal implant market by Type
      • 8.4.6.4.2.India artificial cornea and corneal implant market by Transplant Type
      • 8.4.6.4.3.India artificial cornea and corneal implant market by Disease Indication
      • 8.4.6.4.4.India artificial cornea and corneal implant market by end user
      • 8.4.6.5.Rest of Asia-Pacific
      • 8.4.6.5.1.Rest of Asia-Pacific artificial cornea and corneal implant market by Type
      • 8.4.6.5.2.Rest of Asia-Pacific artificial cornea and corneal implant market by Transplant Type
      • 8.4.6.5.3.Rest of Asia-Pacific artificial cornea and corneal implant market by Disease Indication
      • 8.4.6.5.4.Rest of Asia-Pacific artificial cornea and corneal implant market by end user
  • 8.5.LAMEA
    • 8.5.1.Key market trends and opportunities
    • 8.5.2.Market size and forecast, by country
    • 8.5.3.LAMEA artificial cornea and corneal implant market by Type
    • 8.5.4.LAMEA artificial cornea and corneal implant market by Transplant Type
    • 8.5.5.LAMEA artificial cornea and corneal implant market by Disease Indication
    • 8.5.6.LAMEA artificial cornea and corneal implant market by end user
      • 8.5.6.1.Brazil
      • 8.5.6.1.1.Brazil artificial cornea and corneal implant market by Type
      • 8.5.6.1.2.Brazil artificial cornea and corneal implant market by Transplant Type
      • 8.5.6.1.3.Brazil artificial cornea and corneal implant market by Disease Indication
      • 8.5.6.1.4.Brazil artificial cornea and corneal implant market by end user
      • 8.5.6.2.Saudi Arabia
      • 8.5.6.2.1.Saudi Arabia artificial cornea and corneal implant market, by Type
      • 8.5.6.2.2.Saudi Arabia artificial cornea and corneal implant market, by Transplant Type
      • 8.5.6.2.3.Saudi Arabia artificial cornea and corneal implant market, by Disease Indication
      • 8.5.6.2.4.Saudi Arabia artificial cornea and corneal implant market, by end user
      • 8.5.6.3.South Africa
      • 8.5.6.3.1.South Africa artificial cornea and corneal implant market by Type
      • 8.5.6.3.2.South Africa artificial cornea and corneal implant market, by Transplant Type
      • 8.5.6.3.3.South Africa artificial cornea and corneal implant market, by Disease Indication
      • 8.5.6.3.4.South Africa artificial cornea and corneal implant market, by end user
      • 8.5.6.4.Rest of LAMEA
      • 8.5.6.4.1.Rest of LAMEA artificial cornea and corneal implant market by Type
      • 8.5.6.4.2.Rest of LAMEA artificial cornea and corneal implant market by Transplant Type
      • 8.5.6.4.3.Rest of LAMEA artificial cornea and corneal implant market by Disease Indication
      • 8.5.6.4.4.Rest of LAMEA artificial cornea and corneal implant market by end user

CHAPTER 9:COMPANY PROFILES

  • 9.1.AJL Ophthalmic
    • 9.1.1.Company overview
    • 9.1.2.Company snapshot
    • 9.1.4.Product portfolio
  • 9.2.CorneaGen Inc
    • 9.2.1.Company overview
    • 9.2.2.Company snapshot
    • 9.2.3.Operating business segment
    • 9.2.4.Product portfolio
    • 9.2.5.Key strategic moves and developments
  • 9.3.CorNeat Vision
    • 9.3.1.Company overview
    • 9.3.2.Company snapshot
    • 9.3.3.Operating business segments
    • 9.3.4.Product portfolio
  • 9.4.LinkoCare Life Sciences AB
    • 9.4.1.Company overview
    • 9.4.2.Company snapshot
    • 9.4.3.Operating business segments
    • 9.4.4.Product portfolio
  • 9.5.Presbia plc
    • 9.5.1.Company overview
    • 9.5.2.Operating business segments
    • 9.5.3.Product portfolio
  • 9.6.Mediphacos
    • 9.6.1.Company overview
    • 9.6.2.Company snapshot
    • 9.6.3.Operating business segments
    • 9.6.4.Product portfolio
  • 9.7.Aurolab
    • 9.7.1.Company overview
    • 9.7.2.Company snapshot
    • 9.7.3.Operating business segments
    • 9.7.4.Product portfolio
    • 9.7.5.Business performance
  • 9.8.Cornea Biosciences
    • 9.8.1.Company snapshot
    • 9.8.2.Operating business segments
    • 9.8.3.Product portfolio
  • 9.9.DIOPTEX GmbH
    • 9.9.1.Company overview
    • 9.9.2.Company snapshot
    • 9.9.3.Operating business segments
    • 9.9.4.Product portfolio
  • 9.10.EyeYon Medical
    • 9.10.1.Company overview
    • 9.10.2.Company snapshot
    • 9.10.3.Operating business segments
    • 9.10.4.Product portfolio

LIST OF TABLES

  • TABLE 01.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 02.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR HUMAN CORNEA TYPE, BY REGION, 2020-2028 ($MILLION)
  • TABLE 03.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR ARTIFICIAL CORNEA TYPE, BY REGION, 2020-2028 ($MILLION)
  • TABLE 04.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 05.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR PENETRATING KERATOPLASTY, BY REGION, 2020-2028 ($MILLION)
  • TABLE 06.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR ENDOTHELIAL KERATOPLASTY, BY REGION, 2020-2028 ($MILLION)
  • TABLE 07.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 08.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR FUCHS' DYSTROPHY, BY REGION, 2020-2028 ($MILLION)
  • TABLE 09.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR FUNGAL KERATITIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 10.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR KERATOCONUS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 11.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 12.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 13.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR SPECIALTY CLINICS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 14.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR OTHERS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 15.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY REGION, 2020-2028 ($MILLION)
  • TABLE 16.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 17.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 18.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 19.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 20.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 21.U.S. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 22.U.S. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 23.U.S. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 24.U.S. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 25.CANADA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 26.CANADA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 27.CANADA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 28.CANADA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 29.MEXICO ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 30.MEXICO ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 31.MEXICO ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 32.MEXICO ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 33.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 34.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 35.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 36.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 37.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 38.GERMANY ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 39.GERMANY ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 40.GERMANY ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 41.GERMANY ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 42.FRANCE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 43.FRANCE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 44.FRANCE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 45.FRANCE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 46.UK ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 47.UK ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 48.UK ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 49.UK ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 50.REST OF EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 51.REST OF EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 52.REST OF EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 53.REST OF EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 54.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 55.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 56.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 57.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 58.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 59.JAPAN ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 60.JAPAN ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 61.JAPAN ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 62.JAPAN ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 63.CHINA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 64.CHINA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 65.CHINA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 66.CHINA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 67.AUSTRALIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 68.AUSTRALIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 69.AUSTRALIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 70.AUSTRALIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 71.INDIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 72.INDIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 73.INDIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 74.INDIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 75.REST OF ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 76.REST OF ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 77.REST OF ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 78.REST OF ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 79.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 80.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 81.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 82.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 83.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 84.BRAZIL ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 85.BRAZIL ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 86.BRAZIL ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 87.BRAZIL ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 88.SAUDI ARABIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 89.SAUDI ARABIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 90.SAUDI ARABIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 91.SAUDI ARABIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 92.SOUTH AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 93.SOUTH AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 94.SOUTH AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 95.SOUTH AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 96.REST OF LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 97.REST OF LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
  • TABLE 98.REST OF LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
  • TABLE 99.REST OF LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 100.AJL OPHTHALMIC: COMPANY SNAPSHOT
  • TABLE 101.AJL OPHTHALMIC: OPERATING SEGMENTS
  • TABLE 102.AJL OPHTHALMIC: PRODUCT PORTFOLIO
  • TABLE 103.CORNEAGEN INC: COMPANY SNAPSHOT
  • TABLE 104.CORNEAGEN INC: OPERATING SEGMENTS
  • TABLE 105.CORNEAGEN INC: PRODUCT PORTFOLIO
  • TABLE 106.CORNEAT VISION: COMPANY SNAPSHOT
  • TABLE 107.CORNEAT VISION : OPERATING SEGMENT
  • TABLE 108.CORNEAT VISION: PRODUCT PORTFOLIO
  • TABLE 109.LINKOCARE LIFE SCIENCES AB: COMPANY SNAPSHOT
  • TABLE 110.LINKOCARE LIFE SCIENCES AB: OPERATING SEGMENTS
  • TABLE 111.LINKOCARE LIFE SCIENCES AB: PRODUCT PORTFOLIO
  • TABLE 112.PRESBIA PLC: COMPANY SNAPSHOT
  • TABLE 113.PRESBIA PLC: OPERATING SEGMENTS
  • TABLE 114.PRESBIA PLC: PRODUCT PORTFOLIO
  • TABLE 115.MEDIPHACOS: COMPANY SNAPSHOT
  • TABLE 116.MEDIPHACOS: OPERATING SEGMENTS
  • TABLE 117.MEDIPHACOS: PRODUCT PORTFOLIO
  • TABLE 118.AUROLAB: COMPANY SNAPSHOT
  • TABLE 119.AUROLAB: OPERATING SEGMENTS
  • TABLE 120.AUROLAB: PRODUCT PORTFOLIO
  • TABLE 121.CORNEA BIOSCIENCES: COMPANY SNAPSHOT
  • TABLE 122.CORNEA BIOSCIENCES: OPERATING SEGMENTS
  • TABLE 123.CORNEA BIOSCIENCES: PRODUCT PORTFOLIO
  • TABLE 124.DIOPTEX GMBH: COMPANY SNAPSHOT
  • TABLE 125.DIOPTEX GMBH: OPERATING SEGMENTS
  • TABLE 126.DIOPTEX GMBH: PRODUCT PORTFOLIO
  • TABLE 127.EYEYON MEDICAL: COMPANY SNAPSHOT
  • TABLE 128.EYEYON MEDICAL: OPERATING SEGMENTS
  • TABLE 129.EYEYON MEDICAL: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET: SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05.LOW THREAT OF NEW ENTRANTS
  • FIGURE 06.MODERATE THREAT OF SUBSTITUTION
  • FIGURE 07.MODERATE COMPETITIVE RIVALRY
  • FIGURE 08.MARKET DYNAMICS: ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET
  • FIGURE 09.PREVALENCE OF FUNGAL KERATITIS (CHRONIC BRONCHITIS AND EMPHYSEMA) AMONG AMERICANS, 2020
  • FIGURE 10.NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION, 2020 AND 2050
  • FIGURE 11.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR HUMAN CORNEA TYPE, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 12.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR ARTIFICIAL CORNEA TYPE, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 13.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR PENETRATING KERATOPLASTY, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 14.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR ENDOTHELIAL KERATOPLASTY, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 15.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR FUCHS' DYSTROPHY, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 16.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR FUNGAL KERATITIS, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 17.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR KERATOCONUS, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 18.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 19.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 20.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR OTHERS, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 21.HILL-ROM: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 22.HILL-ROM: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 23.HILL-ROM: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 24.SMITHS MEDICAL: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 25.SMITHS MEDICAL: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 26.SMITHS MEDICAL: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 27.TELEFLEX: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 28.TELEFLEX: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 29.TELEFLEX: REVENUE SHARE, BY REGION, 2020 (%)